SLC26A2 as a key regulator and therapeutic target in hepatocellular carcinoma: evidence from pan-cancer and mechanistic studies.

Hum Genomics · 2026 · PMC13281303 · PMID 42104524

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Moreover, SLC26A2 demonstrated a highly significant ability to differentiate between HCC and non-HCC cases (Fig. 3 C).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.